| Authors: |
Jabbour E; University of Texas MD Anderson Cancer Center, Houston, TX. ejabbour@mdanderson.org., Sandhu KS; City of Hope National Medical Center, Duarte, CA., Shaughnessy P; Sarah Cannon Transplant and Cellular Therapy Program, Methodist Hospital, San Antonio, TX., Logan AC; Hematology, Blood and Marrow Transplantation, and Cellular Therapy Program, University of California at San Francisco, San Francisco, CA., Abedi M; University of California Davis, Davis, CA., Shah BD; Moffitt Cancer Center, Tampa, FL., Bishop MR; The David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL., Park JH; Memorial Sloan Kettering Cancer Center, New York, NY., DeAngelo DJ; Dana-Farber Cancer Institute, Boston, MA., Tholouli E; Manchester Royal Infirmary, Manchester., Yallop D; King's College Hospital NHS Foundation Trust, London., Chaganti S; University Hospitals Birmingham NHS Foundation Trust, Birmingham., Hodby K; University Hospitals Bristol NHS Foundation Trust, Bristol., Barba P; Hospital Universitari Vall d'Hebron-Universitat Autónoma de Barcelona, Barcelona., Guerreiro M; Hospital Universitari I Politècnic La Fe, Valencia., Menne T; Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle., Shang J; Autolus Therapeutics, Rockville, MD., Lao-Sirieix P; Autolus Therapeutics, London., Brugger W; Autolus Therapeutics, Munich, Germany,., Roddie C; University College London Cancer Institute, London. |
